COMMUNIQUÉS West-GlobeNewswire

Cocrystal Pharma Announces Presentation at the RespiDART 2018: Frontiers in Drug Development Against Respiratory Viruses Conference
30/11/2018
- Proprietary technology has the ability to fuel Cocrystal’s pipeline by effectively creating small molecule antiviral therapeutics that are safe, effective, convenient to administer and have the potential to address [...]
IntelGenx Engages Focus Communications for Investor Relations Program
30/11/2018
SAINT LAURENT, Quebec, Nov. 30, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) is pleased to announce the engagement of Focus Communications (“Focus”) to provide [...]
Calithera Biosciences to Participate in the 2018 Citi Global Healthcare Conference
30/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 30, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs directed [...]
Inspire Medical Systems, Inc. Announces Publication of Data From ADHERE Registry
30/11/2018
Data Demonstrated Substantial Reduction in Severity of Obstructive Sleep Apnea with Inspire Therapy Treatment Results from 508 Inspire Therapy Patients Represent Largest International Data Set Generated to Date Data [...]
Brain Scientific To Introduce Two FDA Cleared Devices At American Epilepsy Society Annual Meeting
30/11/2018
NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Brain Scientific Inc. (OTC:BRSF) (“Brain Scientific” or “Company”), a medical device company combining brain analysis software with wireless sensor technologies for [...]
Biohit Oyj’s Financial Reporting and Annual General Meeting in 2019
30/11/2018
Biohit Oyj Financial calendar, November 30, 2018 at 02:45 pm local time (EET) Biohit Oyj will release its financial statements for 2018 on Wednesday 20 th of February 2019 at 9:30 am. The Annual Report, which contains [...]
TG Therapeutics, Inc. Recaps Triple Therapy Data Presentations at the Upcoming 60th American Society of Hematology Annual Meeting and Exposition
30/11/2018
Investor and Analyst Event to be Held on Sunday December 2, 2018 at 7:30 PM PT at the Marriott Gaslamp San Diego with Presentations by Leading Clinical Investigators NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- TG [...]
Lenzilumab Study Published in ‘blood’, the Official Journal of the American Society of Hematology (ASH), First Edition
30/11/2018
Lenzilumab (an anti-GM-CSF antibody) in combination with CAR-T cell therapy prevents cytokine release syndrome and neuro-inflammation while improving durable control of leukemic disease Exponential increase in T cell [...]
Editas Medicine Announces FDA Acceptance of IND Application for EDIT-101
30/11/2018
EDIT-101 set to be the first in vivo CRISPR medicine administered to people anywhere in the world Earns $25 million milestone for IND acceptance from partner Allergan CAMBRIDGE, Mass., Nov. 30, 2018 (GLOBE NEWSWIRE) -- [...]
Neos Therapeutics Announces Realignment of Commercial Organization
30/11/2018
– Strategic assessment leads to new salesforce structure and is expected to accelerate path to profitability – – Company to host conference call today at 8:30am ET – DALLAS and FORT WORTH, Texas, Nov. 30, 2018 (GLOBE [...]
Emerald Health Therapeutics Reports 3rd Quarter 2018 Financial Results and Provides Corporate Update
30/11/2018
Continued production expansion, successful supply fulfillment and product diversification position Emerald for revenue growth VICTORIA, British Columbia, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, [...]
Stemline Therapeutics Highlights Four ELZONRIS Presentations, Including an Oral Presentation, at the Upcoming ASH Meeting
30/11/2018
NEW YORK, Nov. 30, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, highlighted four [...]
Lundbeck and Otsuka report positive phase II data for the combination treatment of brexpiprazole and sertraline for the treatment of Post-Traumatic Stress Disorder (PTSD)
30/11/2018
Valby, Nov. 30, 2018 (GLOBE NEWSWIRE) -- The combination treatment arm of brexpiprazole and sertraline demonstrated improvement in symptoms of PTSD versus placebo (p<0.01) on the primary efficacy endpoint The [...]
La FDA américaine approuve le test de mutation LeukoStrat CDx FLT3 d’Invivoscribe comme CDx et le médicament XOSPATA (fumarate de gilteritinib) d’Astellas pour le traitement des patients atteints de LMA aux États-Unis
30/11/2018
Invivoscribe a également obtenu le remboursement national pour le test CDx au Japon SAN DIEGO, 30 nov. 2018 (GLOBE NEWSWIRE) -- Invivoscribe est heureuse d’annoncer l’approbation par la FDA du test de mutation [...]
Aino Health AB (publ): Aino Health and Finla in joint client project
30/11/2018
November 30, 2018 Aino Health's strategic partner Finla has concluded an agreement with a global player in the process industry regarding Aino HealthManager. The collaboration will begin with 1,700 new subscriptions to [...]
Shire Receives European Approval for TAKHZYRO™ (lanadelumab) subcutaneous injection, for the Preventive Treatment of Hereditary Angioedema
30/11/2018
Intended for Global Audience Shire Receives European Approval for TAKHZYRO™ (lanadelumab) subcutaneous injection, for the Preventive Treatment of Hereditary Angioedema - TAKHZYRO is the first monoclonal antibody for the [...]
Oasmia Pharmaceutical AB (publ) Interim report for the period May – October 2018
30/11/2018
SECOND QUARTER August 1 – October 31, 2018 Consolidated net sales amounted to TSEK 158 compared to TSEK 1,651 in the second quarter the previous year Operating loss was TSEK 22,627 compared to TSEK 22,129 in the second [...]
Eckert & Ziegler BEBIG to restructure its implant business
30/11/2018
Press release Inside and regulated information 30 November 2018, 7:45 (CET) Seneffe, 30 November 2018. Today, the management of Eckert & Ziegler BEBIG SA decided that as of mid-2019, it will focus more strongly on [...]
Eckert & Ziegler BEBIG réorganise son secteur des implants
30/11/2018
Communiqué de presse Information privilégiée et réglementée 30 Novembre 2018, 7:45 (CET) Seneffe, le 30 Novembre 2018. La direction de la société Eckert & Ziegler BEBIG SA a décidé aujourd'hui de se concentrer [...]

Pages